References

  1. Rakotoson JL, Randriamanana D, Rakotomizao JR, Andrianasolo R, Rakotoarivelo R, Andrianarisoa AC. Severe systemic lupus erythematosus induced by isoniazide. Rev Pneumol Clin. 2009; 65(6): 361-4. PubMed | Google Scholar

  2. Masson C, Couchouron T, Audran M. Lupus induits. Rev Rhum.2005 ; 72(2) : 168-175. PubMed | Google Scholar

  3. Sibilia J. Les lupus induits par les médicaments. Rev Rhum. 2002; 69(4): 355-69. PubMed | Google Scholar

  4. Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects form first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003; 167(11):1472-7. PubMed | Google Scholar

  5. Guleria R, Behera D, Jendal SK. Systemic lupus erythematosus during isoniazid therapy. Indian J Chest Allied Sci. 1990; 32:55-8. PubMed | Google Scholar

  6. Pramatarov KD. Drug-induced lupus erythematosus. Clin Dermatol. 1998; 16(3):367-77. PubMed | Google Scholar

  7. Siddiki MA, Khan IA. Isoniazid induced lupus erythematosus presenting with cardiac tamponade. Am J Ther. 2002; 9(2):163-5. PubMed | Google Scholar

  8. Rakoston JL, Randriamanana D, Rakotomizao JR, et al. Lupus érythémateux systémique grave induit par l'isoniazide. Rev Pneumol Clin. 2009; 65(6):361-4. PubMed | Google Scholar

  9. De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther. 2005; 7(3):545-51. PubMed | Google Scholar

  10. Chang C, Gershwin ME. Drugs and autoimmunity ' a contemporary review and mechanistic approach. J Autoimmun. 2010; 34(3):266-75. PubMed | Google Scholar